Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V-5 Immunitor in TB and TB/HIV Patients
NCT01222338Phase 2Completed
- Sponsor
- Lisichansk Regional Tuberculosis Dispensary
- Start
- Jan 2010
- Primary completion
- Dec 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of hepcortespenlisimut-l in Tuberculosis (TB), sponsored by Lisichansk Regional Tuberculosis Dispensary. Started Jan 2010; status: completed.
02
Drugs
hepcortespenlisimut-l
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01222338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222338.